Skip to content. | Skip to navigation

National Cancer Institute U.S. National Institutes of Health


Personal tools

You are here: Home / Biomarkers / HSD17B10



This biomarker is also known as:
  • Short-chain type dehydrogenase/reductase XH98G2,
  • HADH2,
  • MHBD,
  • 17-beta-hydroxysteroid dehydrogenase 10,
  • hydroxyacyl-Coenzyme A dehydrogenase, type II, hydroxyacyl-Coenzyme A dehydrogenase, type II,
  • ABAD,
  • Mitochondrial ribonuclease P protein 2,
  • Type II HADH,
  • mitochondrial ribonuclease P protein 2,
  • HCD2,
  • short chain L-3-hydroxyacyl-CoA dehydrogenase type 2,
  • mental retardation, X-linked, syndromic 10,
  • AB-binding alcohol dehydrogenase,
  • SCHAD,
  • ERAB,
  • MRXS10,
  • short chain type dehydrogenase/reductase XH98G2,
  • DUPXp11.22,
  • 3-hydroxyacyl-CoA dehydrogenase type II,
  • 17b-HSD10,
  • Mitochondrial RNase P protein 2,
  • XH98G2,
  • 3-hydroxyacyl-CoA dehydrogenase type-2,
  • CAMR,
  • hydroxysteroid (17-beta) dehydrogenase 10,
  • short chain dehydrogenase/reductase family 5C, member 1,
  • 3-hydroxy-2-methylbutyryl-CoA dehydrogenase,
  • EC,EC,
  • MRX17,
  • SDR5C1,
  • 17-beta-HSD 10,
  • endoplasmic reticulum-associated amyloid beta-peptide-binding protein,
  • Endoplasmic reticulum-associated amyloid beta-peptide-binding protein,
  • MRPP2,
  • MRX31,
  • amyloid-beta peptide binding alcohol dehydrogenase,
  • mitochondrial RNase P subunit 2,


HSD17B10, hydroxysteroid (17-beta) dehydrogenase 10, is a member of the short-chain dehydrogenase/reductase superfamily. HSD17B10 functions in mitochondrial tRNA maturation and catalyzes the oxidation of a wide variety of fatty acids, alcohols, and steroids. The protein is thought to play a role in the development of Alzheimer's disease. There are several alternatively spliced transcript variants, of which only two have been fully sequenced.


QA State: Curated
Type: Protein
Short Name:
HGNC Name: HSD17B10


There are no datasets associated with this biomarker.


The following organs have data associated with this biomarker…



Phase: Two
QA State: Under Review


No additional breast data is available.

Performance Comment

HSD17B10 was one of numerous potential early detection biomarkers specific to triple-negative breast cancer in multiple pathways identified.


This biomarker is currently being annotated or is under review. You must be logged in or do not have permission to view any additional information. Contact Heather Kincaid at if you should have access to this biomarker.


Mutation Statistics

Gene Name: HSD17B10
UniProt Accession #: Q99714
Mutated Sites Count: 28
Associated Pubmed ID Count 0
CancerDO Count 11
Affected Protein Function Sites Count: 3

View in BioMuta